Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

SMI 998089 / CH0009980894

12’144.59
Pkt
95.46
Pkt
0.79 %
14:25:56

Analysen zu SMI-Werten

16.01.24 UBS Buy Goldman Sachs Group Inc.
15.01.24 Roche Neutral UBS AG
15.01.24 Novartis Buy UBS AG
15.01.24 UBS Kaufen DZ BANK
15.01.24 Roche Underweight JP Morgan Chase & Co.
15.01.24 ABB Neutral JP Morgan Chase & Co.
15.01.24 ABB Sector Perform RBC Capital Markets
12.01.24 Richemont Buy Deutsche Bank AG
12.01.24 Richemont Buy Jefferies & Company Inc.
12.01.24 Swiss Re Overweight JP Morgan Chase & Co.
12.01.24 Richemont Sector Perform RBC Capital Markets
11.01.24 UBS Outperform RBC Capital Markets
11.01.24 Richemont Buy Goldman Sachs Group Inc.
11.01.24 Richemont Overweight JP Morgan Chase & Co.
11.01.24 Roche Underweight JP Morgan Chase & Co.
11.01.24 Givaudan Underperform Jefferies & Company Inc.
10.01.24 Swiss Re Sector Perform RBC Capital Markets
10.01.24 Givaudan Neutral JP Morgan Chase & Co.
10.01.24 Nestlé Overweight JP Morgan Chase & Co.
10.01.24 Holcim Neutral Merrill Lynch & Co., Inc.
10.01.24 Zurich Insurance Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.01.24 Givaudan Market-Perform Bernstein Research
09.01.24 ABB Hold Jefferies & Company Inc.
09.01.24 Roche Equal Weight Barclays Capital
09.01.24 Novartis Neutral JP Morgan Chase & Co.
09.01.24 Givaudan Market-Perform Bernstein Research
08.01.24 Novartis Neutral JP Morgan Chase & Co.
08.01.24 Novartis Neutral UBS AG
08.01.24 Richemont Sector Perform RBC Capital Markets
05.01.24 UBS Outperform RBC Capital Markets
05.01.24 Novartis Buy Deutsche Bank AG
04.01.24 Swiss Re Sector Perform RBC Capital Markets
04.01.24 ABB Market-Perform Bernstein Research
03.01.24 Novartis Neutral JP Morgan Chase & Co.
03.01.24 Richemont Buy UBS AG
03.01.24 Novartis Buy Jefferies & Company Inc.
03.01.24 Roche Hold Jefferies & Company Inc.
02.01.24 Richemont Outperform Bernstein Research
02.01.24 ABB Neutral JP Morgan Chase & Co.
02.01.24 Roche Underweight JP Morgan Chase & Co.